SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $QNCX #biotech–Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, a virtual event, on Wednesday, February 12, 2025 beginning at 2:00 p.m. Easter
More in Trade Show
Trade Show
US Foods to Webcast Presentation at the CAGNY 2025 Conference
ROSEMONT, Ill.–(BUSINESS WIRE)–US Foods Holding Corp. (NYSE: USFD) today announced that Dave Flitman, ...
Trade Show
NRC Health ranked #1 Best in KLAS for Healthcare Experience Management
LINCOLN, Neb.–(BUSINESS WIRE)– #BIK–NRC Health, a leader in advanced technology and data-driven insights ...
Trade Show
Altria to Host Webcast From the Consumer Analyst Group of New York Conference
RICHMOND, Va.–(BUSINESS WIRE)—- $MO #Altria–Altria to Host Webcast from the Consumer Analyst Group ...
